View in EDS HTML Full Text PDF Full Text

Long-term outcomes and treatment patterns in Waldenström macroglobulinemia patients who discontinue Bruton tyrosine kinase inhibitor (BTKi) therapy.

Saved in:
Bibliographic Details
Title: Long-term outcomes and treatment patterns in Waldenström macroglobulinemia patients who discontinue Bruton tyrosine kinase inhibitor (BTKi) therapy.
Authors: Chohan KL; Division of Cancer Medicine, The University of Texas MD Anderson Cancer Center, Houston, TX, USA., Gensini L; Department of Lymphoma & Myeloma, The University of Texas MD Anderson Cancer Center, Houston, TX, USA., Seif S; Department of Lymphoma & Myeloma, The University of Texas MD Anderson Cancer Center, Houston, TX, USA., Sun X; Department of Lymphoma & Myeloma, The University of Texas MD Anderson Cancer Center, Houston, TX, USA., Feng L; Department of Biostatistics, The University of Texas MD Anderson Cancer Center, Houston, TX, USA., Becnel MR; Department of Lymphoma & Myeloma, The University of Texas MD Anderson Cancer Center, Houston, TX, USA., Gaballa MM; Department of Lymphoma & Myeloma, The University of Texas MD Anderson Cancer Center, Houston, TX, USA., Lee HC; Department of Lymphoma & Myeloma, The University of Texas MD Anderson Cancer Center, Houston, TX, USA., Pasvolsky O; Department of Lymphoma & Myeloma, The University of Texas MD Anderson Cancer Center, Houston, TX, USA., Patel KK; Department of Lymphoma & Myeloma, The University of Texas MD Anderson Cancer Center, Houston, TX, USA., Ye JC; Department of Lymphoma & Myeloma, The University of Texas MD Anderson Cancer Center, Houston, TX, USA., Weber DM; Department of Lymphoma & Myeloma, The University of Texas MD Anderson Cancer Center, Houston, TX, USA., Orlowski RZ; Department of Lymphoma & Myeloma, The University of Texas MD Anderson Cancer Center, Houston, TX, USA.; Department of Experimental Therapeutics, The University of Texas MD Anderson Cancer Center, Houston, TX, USA., Thomas SK; Department of Lymphoma & Myeloma, The University of Texas MD Anderson Cancer Center, Houston, TX, USA. sthomas@mdanderson.org.
Source: Blood cancer journal [Blood Cancer J] 2025 Dec 03; Vol. 15 (1), pp. 211. Date of Electronic Publication: 2025 Dec 03.
Publication Type: Letter
Journal Info: Publisher: Nature Pub. Group Country of Publication: United States NLM ID: 101568469 Publication Model: Electronic Cited Medium: Internet ISSN: 2044-5385 (Electronic) Linking ISSN: 20445385 NLM ISO Abbreviation: Blood Cancer J Subsets: MEDLINE; In Process
Database: MEDLINE Ultimate
Full text is not displayed to guests.
FullText Links:
  – Type: pdflink
Text:
  Availability: 1
Header DbId: mdl
DbLabel: MEDLINE Ultimate
An: 41340003
AccessLevel: 2
PubType: Editorial & Opinion
PubTypeId: editorialOpinion
PreciseRelevancyScore: 0
IllustrationInfo
Items – Name: Title
  Label: Title
  Group: Ti
  Data: Long-term outcomes and treatment patterns in Waldenström macroglobulinemia patients who discontinue Bruton tyrosine kinase inhibitor (BTKi) therapy.
– Name: Author
  Label: Authors
  Group: Au
  Data: <searchLink fieldCode="AU" term="%22Chohan+KL%22">Chohan KL</searchLink>; Division of Cancer Medicine, The University of Texas MD Anderson Cancer Center, Houston, TX, USA.<br /><searchLink fieldCode="AU" term="%22Gensini+L%22">Gensini L</searchLink>; Department of Lymphoma & Myeloma, The University of Texas MD Anderson Cancer Center, Houston, TX, USA.<br /><searchLink fieldCode="AU" term="%22Seif+S%22">Seif S</searchLink>; Department of Lymphoma & Myeloma, The University of Texas MD Anderson Cancer Center, Houston, TX, USA.<br /><searchLink fieldCode="AU" term="%22Sun+X%22">Sun X</searchLink>; Department of Lymphoma & Myeloma, The University of Texas MD Anderson Cancer Center, Houston, TX, USA.<br /><searchLink fieldCode="AU" term="%22Feng+L%22">Feng L</searchLink>; Department of Biostatistics, The University of Texas MD Anderson Cancer Center, Houston, TX, USA.<br /><searchLink fieldCode="AU" term="%22Becnel+MR%22">Becnel MR</searchLink>; Department of Lymphoma & Myeloma, The University of Texas MD Anderson Cancer Center, Houston, TX, USA.<br /><searchLink fieldCode="AU" term="%22Gaballa+MM%22">Gaballa MM</searchLink>; Department of Lymphoma & Myeloma, The University of Texas MD Anderson Cancer Center, Houston, TX, USA.<br /><searchLink fieldCode="AU" term="%22Lee+HC%22">Lee HC</searchLink>; Department of Lymphoma & Myeloma, The University of Texas MD Anderson Cancer Center, Houston, TX, USA.<br /><searchLink fieldCode="AU" term="%22Pasvolsky+O%22">Pasvolsky O</searchLink>; Department of Lymphoma & Myeloma, The University of Texas MD Anderson Cancer Center, Houston, TX, USA.<br /><searchLink fieldCode="AU" term="%22Patel+KK%22">Patel KK</searchLink>; Department of Lymphoma & Myeloma, The University of Texas MD Anderson Cancer Center, Houston, TX, USA.<br /><searchLink fieldCode="AU" term="%22Ye+JC%22">Ye JC</searchLink>; Department of Lymphoma & Myeloma, The University of Texas MD Anderson Cancer Center, Houston, TX, USA.<br /><searchLink fieldCode="AU" term="%22Weber+DM%22">Weber DM</searchLink>; Department of Lymphoma & Myeloma, The University of Texas MD Anderson Cancer Center, Houston, TX, USA.<br /><searchLink fieldCode="AU" term="%22Orlowski+RZ%22">Orlowski RZ</searchLink>; Department of Lymphoma & Myeloma, The University of Texas MD Anderson Cancer Center, Houston, TX, USA.; Department of Experimental Therapeutics, The University of Texas MD Anderson Cancer Center, Houston, TX, USA.<br /><searchLink fieldCode="AU" term="%22Thomas+SK%22">Thomas SK</searchLink>; Department of Lymphoma & Myeloma, The University of Texas MD Anderson Cancer Center, Houston, TX, USA. sthomas@mdanderson.org.
– Name: TitleSource
  Label: Source
  Group: Src
  Data: <searchLink fieldCode="JN" term="%22101568469%22">Blood cancer journal</searchLink> [Blood Cancer J] 2025 Dec 03; Vol. 15 (1), pp. 211. <i>Date of Electronic Publication: </i>2025 Dec 03.
– Name: TypePub
  Label: Publication Type
  Group: TypPub
  Data: Letter
– Name: TitleSource
  Label: Journal Info
  Group: Src
  Data: <i>Publisher: </i><searchLink fieldCode="PB" term="%22Nature+Pub%2E+Group%22">Nature Pub. Group </searchLink><i>Country of Publication: </i>United States <i>NLM ID: </i>101568469 <i>Publication Model: </i>Electronic <i>Cited Medium: </i>Internet <i>ISSN: </i>2044-5385 (Electronic) <i>Linking ISSN: </i><searchLink fieldCode="IS" term="%2220445385%22">20445385 </searchLink><i>NLM ISO Abbreviation: </i>Blood Cancer J <i>Subsets: </i>MEDLINE; In Process
PLink https://search.ebscohost.com/login.aspx?direct=true&site=eds-live&db=mdl&AN=41340003
RecordInfo BibRecord:
  BibEntity:
    Identifiers:
      – Type: doi
        Value: 10.1038/s41408-025-01415-5
    Languages:
      – Code: eng
        Text: English
    PhysicalDescription:
      Pagination:
        StartPage: 211
    Titles:
      – TitleFull: Long-term outcomes and treatment patterns in Waldenström macroglobulinemia patients who discontinue Bruton tyrosine kinase inhibitor (BTKi) therapy.
        Type: main
  BibRelationships:
    HasContributorRelationships:
      – PersonEntity:
          Name:
            NameFull: Chohan KL
      – PersonEntity:
          Name:
            NameFull: Gensini L
      – PersonEntity:
          Name:
            NameFull: Seif S
      – PersonEntity:
          Name:
            NameFull: Sun X
      – PersonEntity:
          Name:
            NameFull: Feng L
      – PersonEntity:
          Name:
            NameFull: Becnel MR
      – PersonEntity:
          Name:
            NameFull: Gaballa MM
      – PersonEntity:
          Name:
            NameFull: Lee HC
      – PersonEntity:
          Name:
            NameFull: Pasvolsky O
      – PersonEntity:
          Name:
            NameFull: Patel KK
      – PersonEntity:
          Name:
            NameFull: Ye JC
      – PersonEntity:
          Name:
            NameFull: Weber DM
      – PersonEntity:
          Name:
            NameFull: Orlowski RZ
      – PersonEntity:
          Name:
            NameFull: Thomas SK
    IsPartOfRelationships:
      – BibEntity:
          Dates:
            – D: 03
              M: 12
              Text: 2025 Dec 03
              Type: published
              Y: 2025
          Identifiers:
            – Type: issn-electronic
              Value: 2044-5385
          Numbering:
            – Type: volume
              Value: 15
            – Type: issue
              Value: 1
          Titles:
            – TitleFull: Blood cancer journal
              Type: main
ResultId 1